52
Views
52
CrossRef citations to date
0
Altmetric
Research Article

Preparation and in vitro evaluation of polylactic acid-mitomycin C microcapsules

, , , , &
Pages 181-193 | Received 28 Feb 1986, Accepted 18 Mar 1986, Published online: 27 Sep 2008

References

  • Anderson L. C., Nilson K., Gahmberg C. G. K562—a human erythroleukemic cell line. International Journal of Cancer 1979; 23: 143–147
  • Balis F. M., Holcenberg J. S., Bleyer W. A. Clinical pharmacokinetics of commonly used anticancer drugs. Clinical Pharmacokinetics 1983; 8: 202–232
  • Chabner B. Pharmacologic Principles of Cancer Treatment. W. B. Saunders, Philadelphia 1982; 409
  • Chien Y. W., Lambert H. J., Grant D. E. Controlled drug release from polymeric devices I: Technique for rapid in vitro release studies. Journal of Pharmaceutical Sciences 1974; 63: 365–369
  • den Hartich J., McVie J. G., van Oort W. J., Pinedo H. M. Pharmacokinetics of mitomycin C in humans. Cancer Research 1983; 43: 5017–5021
  • Gurny R., Peppas N. A., Harrington D. D., Banker Q. S. Development of biodegradable and injectable latices for controlled release of potent drugs. Drug Development and Industrial Pharmacy 1981; 7: 1–25
  • Higgins N. A. Condensation polymers of hydroxyacetic acid. U.S. Pat. 2, 676, 954, 1954
  • Higuchi T. Mechanism of sustained-action medication: Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. Journal of Pharmaceutical Sciences 1963; 52: 1145–1149
  • Ishizaka T., Endo K., Koishi M. Preparation of egg albumin microcapsules and microspheres. Journal of Pharmaceutical Sciences 1981; 70: 358–363
  • Kato T., Nemoto R., Mori H., Kumagai I. Sustained-release properties of microencapsulated mitomycin-C with ethylcellulose infused into the renal artery of the dog kidney. Cancer 1980; 46: 14–21
  • Kato T., Nemoto R., Mori H., Takahashi M., Tamakawa Y., Harada M. Arterial chemoembolization with microencapsulated anticancer drug: An approach to selective cancer chemotherapy with sustained effects. Journal of the American Medical Association 1981; 245: 1123–1127
  • Lancaster J. E. The structure of mitomycin A, B, and C and porfiromycin—part I. Journal of American Chemical Society 1962; 84: 3185–3186
  • Leelarasamee N., Howard S. A., Malanga C. J., Hogan T. F., Luzzi L. A., Kandzari S. J., Ma J. K. H. Kinetics of drug release from polylactic acid-hydrocortisone microcapsules. Journal of Microencapsulation 1986; 3: 171–179
  • Low C. E. Preparation of high molecular weight polyhydroxyacetic ester, U.S. Pat. 2, 668, 162, 1954
  • Madoule P., Trampont P., Roche A. Chemoembolization: principles and perspectives. Journal of Microencapsulation 1984; 1: 21–25
  • Senyei A. E., Reich S. D., Gonczy C., Widder K. J. In vivo kinetics of magnetically targeted low-dose doxorubucin. Journal of Pharmaceutical Sciences 1981; 70: 389–391
  • Suzuki K., Price J. C. Microencapsulation and dissolution properties of a neuroleptic in a biodegradable polymer, poly (D, L-lactide). Journal of Pharmaceutical Sciences 1985; 74: 21–24
  • Widder K. J., Flouret G., Senyei A. E. Magnetic microspheres: Synthesis of a parenteral drug carrier. Journal of Pharmaceutical Sciences 1979; 68: 79–82

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.